NA Proactive news snapshot: MegumaGold, The Flowr Corporation, Parallax Health Sciences …

MegumaGold Corp (CSE:NSAU) (OTCMKTS:NSAUF) is to acquire Nova Scotia-focused Osprey Gold Development Ltd (CVE:OS) in a deal which will create a leading precious metal explorer in the Canadian province. The all paper business combination sees Osprey shareholders receive MegumaGold stock equal to an at an exchange ratio of one Meguma share for every two Osprey shares owned. The Flowr Corporation (CVE:FLWR) (OTCMKTS:FLWPF) has provided a global operational update, which includes a headcount restructuring program to better align the company’s strategic objectives in light of the coronavirus (COVID-19) pandemic. In a statement, the Toronto-based company said Tuesday that it has restructured around 25% of its workforce globally, which is expected to result in annual cost savings of around more than $6 million. Parallax Health Sciences Inc (OTCMKTS:PRLX) announced Tuesday that it has selected the antigens and antibodies that it will use as the markers in its rapid coronavirus (COVID-19) diagnostic test. The test is being developed on Parallax’s FDA-cleared and patented Target Diagnostics Test Platform, and the company believes it could be ready for the public by summer.  Seelos Therapeutics Inc (NASDAQ:SEEL) continues to be "extremely pleased" with the side-effect profile of its SLS-002 drug candidate for acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD) and PTSD, the firm said, as it announced additional data from Phase 1 studies. Some of the key highlights of the interim vital signs adverse events (AEs) data from the study, which involves 104 subjects, included that no serious adverse events (SAEs) related to vital signs were observed. NexTech AR Solutions Corp (OTCMKTS:NEXCF) (CSE:NTAR) announced Tuesday that it has integrated Zoom Video Communications Inc (NYSE:ZM) technology with its soon-to-be-acquired live streaming software company, Jolokia, effectively extending the range of Zoom meetings to include 100,000 people at once.  Jolokia, which NexTech has a binding letter of intent to acquire, operates a video training platform called Inferno, which boasts blue-chip customers like Merck, Toyota and CBS. Capstone Turbine Corporation (NASDAQ:CPST), responding to the global coronavirus pandemic, has enacted a new Business Continuity Plan to keep employees safe and to support the company’s financial goals in the June quarter. In a statement Tuesday, the maker of clean-energy microturbines said its leadership team has volunteered to take a 25% temporary salary cut as well as taking any fiscal 2020 executive bonus in equity in lieu of cash, if earned. mCloud Technologies Corp (CVE:MCLD) (OTCMKTS:MCLDF) said Tuesday that it closed out 2019 by adding more than 41,000 assets to its AssetCare platform, easily surpassing the company’s goal of connecting 40,000 assets in buildings, wind turbines, and oil and gas facilities.   The Vancouver-based company said that last year its connected assets grew by 146% year-over-year, compared to the 28,000 connected assets it had in 2018. The company said this included the “conversion of more than C$8 million in legacy oil and gas project services into AssetCare multi-year recurring revenue.” Dunnedin Ventures Inc (CVE:DVI) (OTCMKTS:OTCFF) CEO Claudia Tornquist said the future remained 'bright' for the company and its exploration strategy remained unchanged despite the global coronavirus crisis. "No virus will take away from the quality of our copper porphyry portfolio," she told shareholders in a letter. Media Central Corporation Inc (CSE:FLYY) is boosting its digital sales capabilities with the launch of an affiliate marketing program across all of the firm’s three major publications. The Toronto-based publishing company said in a statement on Tuesday that its affiliate program will allow it to generate new revenue by leveraging its nearly 4.5 million active digital readers for ecommerce sites. The program will also let Media Central take part in digital marketing opportunities with major ecommerce partners like Amazon, Rakuten and PaperJam. LexaGene Holdings Inc (CVE:LXG) (OTCMKTS:LXXGF) said it is adding additional strength to its team as it continues to work towards commercializing its genetic analyzer for pathogen detection. The Beverly, Massachusetts-based company is bringing on medical device expert Steven Armstrong as senior director of operations, it announced Tuesday. Armstrong will play a key role in helping the firm prepare its submission to a US Food & Drug Administration (FDA) Emergency Use Authorization of its commercial technology and other regulatory approvals. Genprex Inc (NASDAQ:GNPX), the gene therapy group, has bolstered its board with three new directors as it executes on its key corporate initiatives. The trio are Brent Longnecker, CEO of Longnecker & Associates; Jose A. Moreno Toscano, CEO at LFB USA Inc; and William R. Wilson, Jr, chairman, president and CEO of Wilson Land & Cattle Co. NetCents Technology Inc (CSE:NC) (OTCMKTS:NTTCF), the cryptocurrency payments specialist, revealed Monday that experienced executive Pat Albright has been appointed as its senior vice president of strategic development to continue the company's current success. Albright was previously marketing and business senior vice president at Moneris Solutions - the largest payment processor in Canada - dealing with 3 billion transactions per year. He has worked with early-stage groups and Fortune 250 firms. Mawson Resources Limited (TSE:MAW)(OTCMKTS:MWSNF) announced Tuesday that it has entered into a subscription agreement with Nagambie Resources Limited (ASX:NAG), which holds tenements in the central Victorian goldfields of Australia. In a statement, Mawson said it has subscribed for 50 million ordinary shares, or 10%, of Nagambie. As a result, Mawson has become a new insider of Nagambie, pursuant to Australian Stock Exchange policies. Nagambie, in turn, has received 8.5 million common shares, or 4.7%, of Mawson shares, which are subject to a statutory four-month hold period and voluntary trading restrictions to be released from such restriction in four equal tranches. Maverix Metals Inc (NYSEAMERICAN:MMX) (TSE:MMX) told shareholders Tuesday that it is monitoring the “unpredictable impacts” of the coronavirus outbreak as it relates to the Vancouver-based company’s multiple royalties. “As the situation regarding COVID-19 is ever-changing, Maverix is unable to determine the impacts that it will have on global mining production levels for the year and has made the decision to withdraw the Company's 2020 attributable gold equivalent ounce guidance,” the company said in a statement. No announcements have been made to date by any of Maverix’s streaming partners that indicates a material impact on mining operations, according to the firm. Maverix has a portfolio of 104 royalties and streams across 18 countries, 14 of which are currently paying. Helix Technologies, Inc (OTCMKTS:HLIX), the leading provider of critical infrastructure services to the legal cannabis industry, said its financial results for fiscal year 2019 will be available on Monday, March 30, 2020, and the company will host a conference call at 4.30pm Eastern Time that day to discuss the financial results and its positioning for growth for 2020 and beyond. There will be a live Q&A following the presentation portion of the call and investors are also encouraged to submit questions via email prior to and during the call by emailing: ir@helixtechnologies.com. The conference call details are: Attendee Dial In: 866-342-8588 or 203-518-9865; Passcode or ID: 10256. Moleculin Biotech, Inc., (NASDAQ:MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, has announced that Walter Klemp, its chairman and chief executive officer, will present at the Life Sciences Investor Forum being held online at LifeSciencesInvestorForum.com on March 26 from 11.30am–12.00pm ET. Link: https://tinyurl.com/032620LSIF. This will be an interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join on the day of the conference, an archived webcast will also be made available after the event. Life Sciences Investor Forum has now completed the agenda for its inaugural event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry. The program opens at 9.15am ET on Thursday, March 26th with the first live webcast at 9.30am ET. Investors can pre-register at: https://tinyurl.com/LSIF032620-AgendaPR. There is no cost to log-in, attend the live presentations or ask questions.